Vanda Pharmaceuticals Correlations
VNDA Stock | USD 4.82 0.05 1.05% |
The current 90-days correlation between Vanda Pharmaceuticals and Nuvation Bio is 0.42 (i.e., Very weak diversification). The correlation of Vanda Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Vanda Pharmaceuticals Correlation With Market
Good diversification
The correlation between Vanda Pharmaceuticals and DJI is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Vanda |
Moving against Vanda Stock
0.67 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
0.57 | CMND | Clearmind Medicine Common | PairCorr |
0.44 | WMT | Walmart | PairCorr |
0.37 | OCEAW | Ocean Biomedical | PairCorr |
0.37 | SCLX | Scilex Holding | PairCorr |
0.31 | CDIOW | Cardio Diagnostics | PairCorr |
0.31 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.65 | HD | Home Depot | PairCorr |
0.63 | JPM | JPMorgan Chase | PairCorr |
0.57 | CAT | Caterpillar | PairCorr |
0.48 | BA | Boeing | PairCorr |
0.45 | DIS | Walt Disney | PairCorr |
0.43 | MSFT | Microsoft Aggressive Push | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Vanda Stock performing well and Vanda Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vanda Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BMRN | 1.13 | 0.13 | 0.09 | 1.04 | 1.47 | 3.04 | 8.07 | |||
PCVX | 2.26 | (0.21) | 0.00 | 3.66 | 0.00 | 3.86 | 19.90 | |||
LQDA | 2.04 | 0.53 | 0.22 | (3.36) | 2.06 | 4.37 | 13.55 | |||
LEGN | 2.34 | 0.19 | 0.09 | (0.54) | 2.55 | 6.15 | 14.84 | |||
TECH | 1.60 | (0.28) | 0.00 | (5.67) | 0.00 | 3.73 | 11.29 | |||
NUVB | 3.24 | (0.54) | 0.00 | 0.36 | 0.00 | 6.88 | 28.03 | |||
TIL | 5.74 | 0.07 | 0.02 | 0.22 | 5.81 | 13.25 | 34.30 | |||
CNTB | 3.42 | (0.24) | 0.00 | 0.17 | 0.00 | 7.59 | 29.84 | |||
NLTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
GRPH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Vanda Pharmaceuticals Corporate Management
Scott Howell | Chief Officer | Profile | |
Mihael MD | President, Founder | Profile | |
Kevin Moran | CFO VP | Profile | |
Elizabeth Every | Head Affairs | Profile | |
Joakim Wijkstrom | Chief Marketing Officer | Profile |